Patrick S. Coffey

White Collar Defense

• Lead trial counsel in DOJ and SEC investigations of private equity funds in alleged scheme to defraud investors in connection with fund asset valuations.
• Co-lead counsel in criminal prosecution of orthopedic group and surgeon in alleged scheme involving kickback arrangements with compounding pharmacies.
• Defense of sales and marketing executive in DOJ Antitrust Division criminal investigation involving alleged price fixing and market allocation in generic pharmaceutical industry.
• Lead counsel in defense of ready-mix company and executive in DOJ criminal investigation relating to state and federal set-aside contracts and parallel civil false claims investigation and litigation.
• Lead counsel for health system in disclosure and resolution of Stark Law and anti-kickback issues relating to practice lease agreements with physician groups.
• Lead counsel for chief executive and behavioral health clinic in DOJ and state fraud control unit investigations, including defense of qui tam litigation relating to alleged improper testing and telehealth services.
• Lead counsel for multispecialty physician group in DOJ investigation and related qui tam litigation involving alleged Stark Law and related violations in connection with compensation arrangements.
• Lead counsel for current and former executives of major aerospace/defense companies in multiple DOJ investigations and false claims litigation relating to government procurement contracts.
• Co-lead counsel for healthcare CEO in SEC investigation and Wells process relating to alleged fraudulent disclosures and reporting matters.
• Co-lead counsel for executive in cross-border investigation of marketing practices by implantable device company.
• Representation of Chinese manufacturer and affiliated distributors in tax disputes and related investigations by IRS and DOJ.
• Co-lead counsel in defense of corporate executive in DOJ and SEC cases alleging accounting fraud.
• Representation of former employees in DOJ criminal investigation and prosecution of putative violations associated with handling asbestos-containing materials.
• Lead counsel for health system in internal investigation and disclosure to DOJ of physician group billing fraud and resolution of FCA claims and civil litigation against responsible providers.
• Representation of public company executive in SEC investigation, Wells process and enforcement proceedings relating to revenue recognition and reporting of financial arrangements.
• Co-counsel for individual clients in criminal tax investigations by DOJ and Internal Revenue Service relating to off-shore accounts and alleged evasion of tax obligations.
• Lead defense counsel for executives in DOJ and SEC investigations of potential FCPA violations relating to business operations in various overseas countries.
• Lead counsel in defense of multiple DOJ investigations and enforcement proceedings, including whistleblower cases, relating to hospital and physician arrangements and alleged kickbacks and Stark violations.
• Representation of current and former pharmaceutical company executives in DOJ and attorneys general investigations into off-label marketing and sale of drugs.
• Defense of companies and executives in attorneys general investigations and enforcement proceedings involving business practices under the Martin Act and other consumer protection statutes.
• Secured dismissal with prejudice of whistleblower suit filed against large integrated health system under the Illinois Insurance Claims Fraud Prevention Act, alleging cost reports provided under cost-plus contracts resulted in substantial overpayments.

Other Investigations

• Representation of private equity funds and managing members in SEC investigations relating to alleged fraudulent disclosures and accounting practices.
• Lead counsel for financial institution in internal investigation relating to executive violations of regulatory and bank policies concerning lending practices.
• Representation of bank directors in OCC investigation and enforcement proceeding relating to executive compensation and oversight.
• Representation of medical device company executive in DOJ and state attorneys general investigations relating to marketing and sale of spinal device.
• Lead counsel in defense of chief financial officer in SEC investigation and enforcement proceeding relating to alleged fraud in financial reporting and revenue recognition accounting.
• Representation of life sciences company in DOJ and FDA investigations concerning alleged CGMP violations.

Other Experience

• Representation of private equity firm in litigation and DOJ disclosure relating to post-closing price adjustment claims stemming from allegedly improper healthcare billing practices.
• Representation of healthcare systems in resolution of healthcare fraud and abuse exposure issues through voluntary disclosures and other corrective actions.
• Co-lead counsel for companies in DOJ investigations involving the pricing, marketing and distribution of medical devices and pharmaceuticals.